While this study demonstrated that ORes exerted anti-breast cancer activity by inducing ferroptosis through the inhibition of the EGFR/PI3K/AKT/GPX4 signalling axis, it is important to note some limitations. This evidence concerns the gene GPX4 and breast carcinoma.